| MEDI | Sunday, 28 August 2005 | ||
9:00 AM-12:00 PM Washington DC Convention Center -- Ballroom A, Oral | |||
Neuropathic Pain | |||
| Organizer, Presidings: | Subramaniam Ananthan John A. Butera | ||
| 9:00 AM | Introductory Remarks | ||
| 9:05 AM | 1 | Neuropathic pain: Overview and therapeutic strategies Jeffrey D. Kennedy | |
| 9:40 AM | 2 | Carboxylate bioisosteres of gabapentin that target the alpha-2-delta protein Jacob B. Schwarz, Carmen E. Burgos-Lepley, Lisa R. Thompson, Simon A. Osborne, Justin S. Bryans, Mark J. Field, Dic Williams, David J. Dooley, Ayman El-Kattan, Charles P. Taylor, David J. Wustrow | |
| 10:15 AM | 3 | Novel series of potent and selective antagonists of mGluR1: Possible use in the treatment of neuropathic pain Jeffrey M. Schkeryantz | |
| 10:50 AM | 4 | The identification of KCNQ channel modulators and their potential use in disorders associated with excessive neuronal excitability Grant McNaughton-Smith | |
| 11:25 AM | 5 | Novel urea and amide TRPV1 antagonists as potential new therapeutic agents for the treatment of neuropathic pain Susan M Westaway | |
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
The 230th ACS National Meeting, in Washington, DC, Aug 28-Sept 1, 2005